Evidence map›Paper›PMID 32441820›Full record

ArticlePrenatal diagnosis2020

Making the most of the first prenatal visit: The challenge of expanding prenatal genetic testing options and limited clinical encounter time.

Ruth M Farrell, Madelyn Pierce, Christina Collart, Brownsyne Tucker Edmonds, Edward Chien, Marissa Coleridge, Susannah L Rose, Uma Perni, Richard Frankel

Abstract read
In one paragraph

Article in Prenatal diagnosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Identifying Strategies to Improve Shared Decision Making for Pregnant Patients' Decisions about Prenatal Genetic Screens and Diagnostic Tests.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Trial
  3. Trust As the Foundation for Informed Decision-Making in Prenatal Genetic Screening and Diagnostic Testing: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruth M FarrellObstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Madelyn PierceObstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Christina CollartObstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Brownsyne Tucker EdmondsDepartment of Obstetrics and Gynecology, University of Indiana, Indianapolis, Indiana, USA.
Edward ChienObstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Marissa ColeridgeGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Susannah L RoseCenter for Bioethics, Cleveland Clinic, Cleveland, Ohio, USA.
Uma PerniObstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Richard FrankelCleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.

Funding

Ensuring Patients' Informed Access to Noninvasive Prenatal TestingR01HG010092 · NHGRI · CLEVELAND CLINIC LERNER COM-CWRU · PI Ruth Farrell · 2017 to 2026
$5.9M
NHGRI NIH HHS R01 HG010092NHGRI NIH HHS R01HG010092
6 · The paper itself

Abstract

objectiveAdvances in prenatal genetics place additional challenges as patients must receive information about a growing array of screening and testing options. This raises concerns about how to achieve a shared decision-making process that prepares patients to make an informed decision about their choices about prenatal genetic screening and testing options, calling for a reconsideration of how healthcare providers approach the first prenatal visit.

methodsWe conducted interviews with 40 pregnant women to identify components of decision-making regarding prenatal genetic screens and tests at this visit. Analysis was approached using grounded theory.

resultsParticipants brought distinct notions of risk to the visit, including skewed perceptions of baseline risk for a fetal genetic condition and the implications of screening and testing. Participants were very concerned about financial considerations associated with these options, ranking out-of-pocket costs on par with medical considerations. Participants noted diverging priorities at the first visit from those of their healthcare provider, leading to barriers to shared decision-making regarding screening and testing during this visit.

conclusionResearch is needed to determine how to restructure the initiation of prenatal care in a way that best positions patients to make informed decisions about prenatal genetic screens and tests.

Indexed as

Decision MakingGenetic TestingPrenatal CareAdultAttitude to HealthCell-Free Nucleic AcidsFemaleHumansMass ScreeningMaternal Serum Screening TestsOffice VisitsPatient ParticipationPerceptionPregnancyPrenatal DiagnosisRisk AssessmentCell-Free Nucleic Acids

Identifiers

PMID32441820
PMCPMC10114520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.